These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 18311131)
1. Synthetic GPI array to study antitoxic malaria response. Kamena F; Tamborrini M; Liu X; Kwon YU; Thompson F; Pluschke G; Seeberger PH Nat Chem Biol; 2008 Apr; 4(4):238-40. PubMed ID: 18311131 [TBL] [Abstract][Full Text] [Related]
2. GPIs on a chip. Ferguson MA Nat Chem Biol; 2008 Apr; 4(4):223-4. PubMed ID: 18347586 [No Abstract] [Full Text] [Related]
3. Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria. Schofield L; Hewitt MC; Evans K; Siomos MA; Seeberger PH Nature; 2002 Aug; 418(6899):785-9. PubMed ID: 12181569 [TBL] [Abstract][Full Text] [Related]
4. Naturally elicited antibodies to glycosylphosphatidylinositols (GPIs) of Plasmodium falciparum require intact GPI structures for binding and are directed primarily against the conserved glycan moiety. Naik RS; Krishnegowda G; Ockenhouse CF; Gowda DC Infect Immun; 2006 Feb; 74(2):1412-5. PubMed ID: 16428795 [TBL] [Abstract][Full Text] [Related]
5. Synthetic glycosylphosphatidylinositol microarray reveals differential antibody levels and fine specificities in children with mild and severe malaria. Tamborrini M; Liu X; Mugasa JP; Kwon YU; Kamena F; Seeberger PH; Pluschke G Bioorg Med Chem; 2010 Jun; 18(11):3747-52. PubMed ID: 20471845 [TBL] [Abstract][Full Text] [Related]
6. A convergent, versatile route to two synthetic conjugate anti-toxin malaria vaccines. Seeberger PH; Soucy RL; Kwon YU; Snyder DA; Kanemitsu T Chem Commun (Camb); 2004 Aug; (15):1706-7. PubMed ID: 15278147 [TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin G (IgG) responses to Plasmodium falciparum glycosylphosphatidylinositols are short-lived and predominantly of the IgG3 subclass. Boutlis CS; Fagan PK; Gowda DC; Lagog M; Mgone CS; Bockarie MJ; Anstey NM J Infect Dis; 2003 Mar; 187(5):862-5. PubMed ID: 12599061 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates. Flueck C; Frank G; Smith T; Jafarshad A; Nebie I; Sirima SB; Olugbile S; Alonso P; Tanner M; Druilhe P; Felger I; Corradin G Vaccine; 2009 May; 27(20):2653-61. PubMed ID: 19428875 [TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles. Lalitha PV; Biswas S; Pillai CR; Saxena RK Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786 [TBL] [Abstract][Full Text] [Related]
10. Expression and immunogenicity of the Plasmodium falciparum circumsporozoite protein: the role of GPI signal sequence. Ophorst OJ; Radosević K; Ouwehand K; van Beem W; Mintardjo R; Sijtsma J; Kaspers J; Companjen A; Holterman L; Goudsmit J; Havenga MJ Vaccine; 2007 Feb; 25(8):1426-36. PubMed ID: 17161889 [TBL] [Abstract][Full Text] [Related]
13. Induction and displacement of an helix in the 6725 SERA peptide analogue confers protection against P. falciparum malaria. Alba MP; Salazar LM; Purmova J; Vanegas M; Rodriguez R; Patarroyo ME Vaccine; 2004 Mar; 22(9-10):1281-9. PubMed ID: 15003658 [TBL] [Abstract][Full Text] [Related]
14. Malaria vaccines - The long synthetic peptide approach: Technical and conceptual advancements. Olugbile S; Habel C; Servis C; Spertini F; Verdini A; Corradin G Curr Opin Mol Ther; 2010 Feb; 12(1):64-76. PubMed ID: 20140818 [TBL] [Abstract][Full Text] [Related]
15. The immunogenic properties of protozoan glycosylphosphatidylinositols in the mosquito Anopheles gambiae. Arrighi RB; Debierre-Grockiego F; Schwarz RT; Faye I Dev Comp Immunol; 2009 Feb; 33(2):216-23. PubMed ID: 18822312 [TBL] [Abstract][Full Text] [Related]
16. Glycosylphosphatidylinositol anchors of Plasmodium falciparum: molecular characterization and naturally elicited antibody response that may provide immunity to malaria pathogenesis. Naik RS; Branch OH; Woods AS; Vijaykumar M; Perkins DJ; Nahlen BL; Lal AA; Cotter RJ; Costello CE; Ockenhouse CF; Davidson EA; Gowda DC J Exp Med; 2000 Dec; 192(11):1563-76. PubMed ID: 11104799 [TBL] [Abstract][Full Text] [Related]
17. Molecular structure of the "low molecular weight antigen" of Toxoplasma gondii: a glucose alpha 1-4 N-acetylgalactosamine makes free glycosyl-phosphatidylinositols highly immunogenic. Striepen B; Zinecker CF; Damm JB; Melgers PA; Gerwig GJ; Koolen M; Vliegenthart JF; Dubremetz JF; Schwarz RT J Mol Biol; 1997 Mar; 266(4):797-813. PubMed ID: 9102470 [TBL] [Abstract][Full Text] [Related]
18. Immunological Evaluation of Synthetic Glycosylphosphatidylinositol Glycoconjugates as Vaccine Candidates against Malaria. Malik A; Steinbeis F; Carillo MA; Seeberger PH; Lepenies B; Varón Silva D ACS Chem Biol; 2020 Jan; 15(1):171-178. PubMed ID: 31573796 [TBL] [Abstract][Full Text] [Related]
19. Toward the Development of the Next Generation of a Rapid Diagnostic Test: Synthesis of Glycophosphatidylinositol (GPI) Analogues of Plasmodium falciparum and Immunological Characterization. Gurale BP; He Y; Cui X; Dinh H; Dhawane AN; Lucchi NW; Udhayakumar V; Iyer SS Bioconjug Chem; 2016 Dec; 27(12):2886-2899. PubMed ID: 27792303 [TBL] [Abstract][Full Text] [Related]
20. Age-dependent impairment of IgG responses to glycosylphosphatidylinositol with equal exposure to Plasmodium falciparum among Javanese migrants to Papua, Indonesia. Hudson Keenihan SN; Ratiwayanto S; Soebianto S; Krisin ; Marwoto H; Krishnegowda G; Gowda DC; Bangs MJ; Fryauff DJ; Richie TL; Kumar S; Baird JK Am J Trop Med Hyg; 2003 Jul; 69(1):36-41. PubMed ID: 12932094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]